Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:57 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1393–1416 of 8,270 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Hepatitis B Infection
Interventions: Tenofovir Disoproxil Fumarate, Lamivudine Oral Solution; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 16 Years to 50 Years · Female only
Enrollment: 334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Pediatric ALL, Adolescent
Interventions: Observation; Other
Lead sponsor: MultiCare Health System Research Institute; Other
Eligibility: 3 Years to 25 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Puyallup, Washington

Conditions: Breast Cancer
Interventions: Full Field Digital Mammogram (Planmed Sophie Nuance); Device
Lead sponsor: Planmed Oy; Industry
Eligibility: 40 Years to 85 Years · Female only
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: Memphis, Tennessee • Houston, Texas

Conditions: Long QT Syndrome, Abnormalities, Drug-Induced
Interventions: Progesterone, Ibutilide, Testosterone, Placebo; Drug
Lead sponsor: Indiana University; Other
Eligibility: 50 Years to 99 Years
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 3
States / cities: Indianapolis, Indiana

Conditions: Sleep Quality, Compliance, Physical Activity, Sedentary Behaviors, Sleep Duration
Interventions: Time Restricted Eating, Control; Behavioral
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 26 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Leukemia
Interventions: AEG35156; Drug
Lead sponsor: Aegera Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 6
States / cities: Los Angeles, California • Denver, Colorado • Chicago, Illinois + 3 more

Conditions: Attention Deficit/Hyperactivity Disorder, Inattention
Interventions: Screening, Resource Packet, Resource Navigation, Care as usual; Other
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 16 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Chicago, Illinois • Boston, Massachusetts

Conditions: ADHD
Interventions: EndeavorOTC; Device
Lead sponsor: Akili Interactive Labs, Inc.; Industry
Eligibility: Not listed
Enrollment: 198 participants
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Overweight, Obesity, Atherosclerotic Cardiovascular Disease (ASCVD)
Interventions: No treatment given; Other
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 45 Years and older
Enrollment: 45,456 participants
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Plainsboro, New Jersey

Conditions: Spinocerebellar Ataxia - All Sub-types, Friedreich's Ataxia
Interventions: Ataxia rating scale; Other
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Adult Spinal Deformity, Scoliosis, Kyphosis, Sagittal Imbalance
Interventions: Index or spine revision surgery for complex adult spinal deformity; Procedure
Lead sponsor: International Spine Study Group Foundation; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2032
U.S. locations: 17
States / cities: La Jolla, California • Sacramento, California • San Francisco, California + 11 more

Conditions: COVID-19, Pregnancy Complications, Mental Health Wellness 1, Anxiety, Depression, Ptsd, Coronavirus
Interventions: This is an online survey with no intervention.; Other
Lead sponsor: Pregistry; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 6,894 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Maternal Behavior, Depression
Interventions: Well Child Visits; Behavioral
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 13 Years to 67 Years
Enrollment: 1,625 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Diet Habit
Interventions: Healthy Default Kids' Beverage Policy; Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 3,480 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: Minneapolis, Minnesota • Research Triangle Park, North Carolina • Philadelphia, Pennsylvania

Conditions: HIV
Interventions: Lenacapavir long-acting, Standard of Care (SOC); Drug · Other
Lead sponsor: Kelley-Ross & Associates, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Influenza Vaccine Effectiveness
Interventions: Not listed
Lead sponsor: MedImmune LLC; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 4,121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 8
States / cities: Gainesville, Florida • Bloomington, Minnesota • Winston-Salem, North Carolina + 5 more

Conditions: Pre-Exposure Prophylaxis of HIV Infection
Interventions: Oral Lenacapavir (LEN), F/TDF, Sub-cutaneous (SC) Lenacapavir (LEN), Placebo SC LEN, PTM F/TDF, PTM Oral LEN, F/TAF (for US participants only); Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 16 Years and older
Enrollment: 3,292 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2028
U.S. locations: 60
States / cities: Birmingham, Alabama • Loma Linda, California • Los Angeles, California + 43 more

Conditions: Adults, Older Adults
Interventions: RLIC, Sham conditioning, Balance training; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 40 Years to 80 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Reproductive Health
Interventions: Women's Reproductive Health, Online sexual health content; Behavioral
Lead sponsor: Oregon Center for Applied Science, Inc.; Industry
Eligibility: 25 Years to 55 Years · Female only
Enrollment: 333 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Hemophilia B
Interventions: REGV131, LNP1265; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 2 Years and older · Male only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2047
U.S. locations: 17
States / cities: Phoenix, Arizona • Los Angeles, California • Sacramento, California + 12 more

Conditions: Geographic Atrophy, Age-Related Macular Degeneration
Interventions: K8; Drug
Lead sponsor: Inflammasome Therapeutics; Industry
Eligibility: 50 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 9
States / cities: Loma Linda, California • Lexington, Kentucky • Portland, Maine + 6 more

Conditions: ADHD, Autism, Bipolar I Disorder, Conduct Disorder, Oppositional Defiant Disorder
Interventions: Brexpiprazole; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 9
States / cities: Little Rock, Arkansas • Rogers, Arkansas • Long Beach, California + 4 more

Conditions: Obesity, Childhood, Obesity
Interventions: Bonding-Evoked Oxytocin, Distress Relieving Effects of Sucrose, Hedonic Response to Sucrose, Typical versus Challenging Feeding-Social, Caloric Compensation-Social, Ability to Delay Gratification for Food in Infants-Social Task (ATDG-FIT-Social); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 0 Days and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Multiple Myeloma
Interventions: melphalan, topotecan (TPT), Autologous Stem Cell Rescue; Drug · Procedure
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2018
U.S. locations: 1
States / cities: Tampa, Florida

Search by objective public record fields.

Reducing Vertical Transmission of Hepatitis B in Africa

Pediatric Normative Markerless Movement Analysis

Study to Compare the Diagnostic Accuracy of Nuance Full-Field Digital Mammography to Screen-Film Mammography

Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening

Changes in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women

AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen

Pilot Testing PREschooler Care, Community Resources, Advocacy, Referral, Education (PRE-CARE)

EndeavorOTC™ Prospective Product Registry

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World

Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)

Complex Adult Deformity Surgery (CADS)

Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic

Interconception Care at the University of Mississippi Medical Center

Evaluating a Healthy Restaurant Kids Meals Policy

Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV Infection

Effects of RLIC on Motor Learning in Middle-aged and Older Adults

Mid-life Women: Preventing Unintended Pregnancy and STIs

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders

Mother-Baby Study - Observational

Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.